Attached files
file | filename |
---|---|
10-K - FORM 10-K - MEDICINES CO /DE | y83232e10vk.htm |
EX-2.3 - MEDICINES CO /DE | y83232exv2w3.htm |
EX-31.2 - EX-31.2 - MEDICINES CO /DE | y83232exv31w2.htm |
EX-21 - EX-21 - MEDICINES CO /DE | y83232exv21.htm |
EX-23 - EX-23 - MEDICINES CO /DE | y83232exv23.htm |
EX-32.2 - EX-32.2 - MEDICINES CO /DE | y83232exv32w2.htm |
EX-31.1 - EX-31.1 - MEDICINES CO /DE | y83232exv31w1.htm |
EX-10.42 - EX-10.42 - MEDICINES CO /DE | y83232exv10w42.htm |
EX-10.41 - EX-10.41 - MEDICINES CO /DE | y83232exv10w41.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of The Medicines Company (the Company) for
the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Clive A. Meanwell, Chairman and Chief Executive Officer of the Company,
hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
By: | /s/ Clive A. Meanwell
|
|||||
Chairman and Chief Executive Officer |
Dated: March 16, 2010
A signed original of this written statement required by Section 906 has been provided to The
Medicines Company and will be retained by The Medicines Company and furnished to the SEC or its
staff upon request